Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
about
Qualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion Sup35pMitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.The effect of 'Candidatus Liberibacter asiaticus' infection on the proteomic profiles and nutritional status of pre-symptomatic and symptomatic grapefruit (Citrus paradisi) plantsDrosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAPMitochondrial dysfunction in genetic animal models of Parkinson's diseaseStable isotope labeling with amino acids in Drosophila for quantifying proteins and modifications.Proteomics in animal models of Alzheimer's and Parkinson's diseases.Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.Recent advances in using Drosophila to model neurodegenerative diseases.Chemical measurements in Drosophila.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Mitochondrial metals as a potential therapeutic target in neurodegeneration.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.Energy matters: mitochondrial proteomics for biomedicine.New insight into neurodegeneration: the role of proteomics.The cuticular nature of corneal lenses in Drosophila melanogaster.Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid.Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress.α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton.
P2860
Q28740450-3E71E396-A0CD-40DF-ADB4-57EF510064B4Q33840243-4D66821F-A1B4-4B72-B51C-697CF259EEFAQ34442714-5ECAEFFA-4CBA-4218-8B60-C6646B9DB018Q34664943-C7E45D1F-6234-48DE-B42E-0855B81101FCQ34787767-712A3048-CAE8-4C32-84EC-FDCE101F05E3Q35767234-123CA883-55DB-4C0A-B0AD-60C88C9AF4FAQ35799109-8DD410FA-E8A0-4D24-BE60-A9FF4C1AEA33Q36237038-3BA947D8-77C5-4679-95D5-B5F03A109CB0Q37071539-9E0D2EE3-23F9-4FB9-96B5-F1C3CF515FA8Q37190514-084017FB-824A-441E-92A4-7CBC6466C263Q37398849-04390E70-0368-4E04-BE00-15B8C16AFDCBQ37448324-53535EFA-4F6C-4639-A631-7CFD0C9E39B2Q37449842-1069801D-7FB4-4807-BAF5-084BB30F816AQ37685124-CE6FD276-87CB-4D04-AC5E-24A42F059408Q37686294-2899ABB9-9FA9-47F7-9D7F-14816584D761Q37727186-5215DD9B-3F7F-4B26-A6CB-A7CC80578169Q37755118-44AA0E9E-3116-4BB5-9A67-0F4E0AAE629FQ37775037-DB8A391C-6788-40EE-ABDD-43167A4D3371Q37829412-245E1E53-101F-44DF-B967-B6C88022A3A5Q38170010-433A6B9B-D1A5-4968-8EBC-D541086405A4Q38687096-27073A31-E9FC-4AE3-A805-0BFD98979D9EQ38786158-6B9997B2-5A2F-4ACB-AACA-78C132783201Q43061595-B5A4D2AD-0556-4B1F-AA8C-D3F29A3E5382Q47911489-96953254-1AE9-4DD1-BFF7-AC2A124E1C0D
P2860
Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Quantitative proteomics of a p ...... la model of Parkinson disease.
@ast
Quantitative proteomics of a p ...... la model of Parkinson disease.
@en
type
label
Quantitative proteomics of a p ...... la model of Parkinson disease.
@ast
Quantitative proteomics of a p ...... la model of Parkinson disease.
@en
prefLabel
Quantitative proteomics of a p ...... la model of Parkinson disease.
@ast
Quantitative proteomics of a p ...... la model of Parkinson disease.
@en
P2093
P2860
P921
P1476
Quantitative proteomics of a p ...... la model of Parkinson disease.
@en
P2093
David E Clemmer
Renã A Sowell
Thomas C Kaufman
Zhiyin Xun
P2860
P304
P356
10.1074/MCP.M700467-MCP200
P577
2008-03-18T00:00:00Z